CompoAtlas

Tri-Chol CANADA

Natural health product licensed in Canada

Licence holder
Biotics Research Corporation
NPN or DIN-HM
80046537
Status
Active licence
Licence date
26 November 2013
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Citrus aurantium

Source : Pelure (fruit)

Potency : 6 % Synephrine

25 mgNot calculated
Reynoutria multiflora

Source : Racine

65 mgNot calculated
(bêta-hydroxyéthyl)triméthylammonium

Source : Bitartrate de choline

30 mgNot calculated

Non-medicinal ingredients

Amidon de pois, Gélatine, Eau

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Capsule2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Choline is a factor in the maintenance of good health and helps to support liver function. Source of Japanese knotweed. Niacin helps the body to metabolize carbohydrates, fats and proteins.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80046537

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line